- $10.24bn
- $12.81bn
- $5.78bn
- 67
- 69
- 96
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.7 | ||
| PEG Ratio (f) | 0.82 | ||
| EPS Growth (f) | 11.94% | ||
| Dividend Yield (f) | 0.85% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.93 | ||
| Price to Tang. Book | 2.13 | ||
| Price to Free Cashflow | 7.69 | ||
| Price to Sales | 1.77 | ||
| EV to EBITDA | 8.65 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5% | ||
| Return on Equity | 21.87% | ||
| Operating Margin | 25.16% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 4,738.56 | 5,121.35 | 5,226.74 | 5,447.53 | 5,778.07 | 5,892.87 | 6,193.43 | 5% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -0.6 | +47.8 | -10.61 | +11.32 | +20.38 | +12.74 | +10.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company’s segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.
Directors
- Gary Coleman CCH (68)
- Larry Hutchison CCH (67)
- Frank Svoboda CFO (59)
- Steven DiChiaro CEX (54)
- Steven Greer CEX (48)
- Bill Leavell CEX (58)
- Kenneth Matson CEX (53)
- James McPartland EVP (54)
- Jennifer Haworth EVP (47)
- R. Brian Mitchell EVP (57)
- Michael Majors EVP (58)
- J. Matthew Darden EVP (50)
- Thomas Kalmbach EVP (56)
- M. Shane Henrie SVP (47)
- Christopher Moore SVP (50)
- Mary Henderson SVP (57)
- Pamela Ramirez SVP (48)
- Joel Scarborough SVP
- Dolores Skarjune SVP
- Rebecca Zorn SVP (48)
- Robert Ingram LED (72)
- Charles Adair IND (73)
- Linda Addison IND (69)
- Marilyn Alexander IND (69)
- Cheryl Alston IND (55)
- Mark Blinn IND (59)
- James Brannen IND (59)
- Jane Buchan IND (57)
- Steven Johnson IND (70)
- Darren Rebelez IND (55)
- Mary Thigpen IND (61)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 29th, 1979
- Public Since
- December 31st, 1980
- No. of Shareholders
- 1,859
- No. of Employees
- 3,732
- Sector
- Insurance
- Industry
- Financials
- Exchange
New York Stock Exchange- Shares in Issue
- 83,242,754
- Address
- 3700 South Stonebridge Drive, MCKINNEY, 75070
- Web
- https://home.globelifeinsurance.com/
- Phone
- +1 9725694000
- Auditors
- Deloitte & Touche LLP
Upcoming Events for GL
Q1 2025 Globe Life Inc Earnings Call
Dividend For GL_pd.N - 0.2656 USD
Dividend For G1LL34.SA - 0.0536 BRL
Dividend For GL.N - 0.2700 USD
Q2 2025 Globe Life Inc Earnings Release
Q3 2025 Globe Life Inc Earnings Release
Similar to GL
Aegon
New York Stock Exchange
Aflac
New York Stock Exchange
Allstate
New York Stock Exchange
Ambac Financial
New York Stock Exchange
American Financial
New York Stock Exchange
FAQ
What is the Globe Life share price?
As of Today at 20:52 UTC, shares in Globe Life are trading at $122.96. This share price information is delayed by 15 minutes.
How has the Globe Life share price performed this year?
Shares in Globe Life last closed at $122.96 and the price had moved by +62.77% over the past 365 days. In terms of relative price strength the Globe Life share price has outperformed the S&P500 Index by +50.25% over the past year.
What are the analyst and broker recommendations for Globe Life?
The overall consensus recommendation for Globe Life is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Globe Life dividend yield?
The Globe Life dividend yield is 0.77% based on the trailing twelve month period.
Does Globe Life pay a dividend?
Last year, Globe Life paid a total dividend of $0.95, and it currently has a trailing dividend yield of 0.77%.Looking ahead, shares in Globe Life are due to go ex-dividend on 2025-07-03 and the next dividend pay date is 2025-05-01.
When does Globe Life next pay dividends?
Globe Life are due to go ex-dividend on 2025-07-03 and the next dividend pay date is 2025-05-01. The historic dividend yield on Globe Life shares is currently 0.77%.
How do I buy Globe Life shares?
To buy shares in Globe Life you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Globe Life?
As of the previous close price of $122.96, shares in Globe Life had a market capitalisation of $10.24bn.
Where are Globe Life shares listed?
Here are the trading details for Globe Life:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: GL
What kind of share is Globe Life?
Based on an overall assessment of its quality, value and momentum Globe Life is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Globe Life share price forecast for 2025?
The analyst consensus target price for shares in Globe Life is $140.80. That is 14.51% above the last closing price of $122.96.
Analysts covering Globe Life currently have a consensus Earnings Per Share (EPS) forecast of $13.68 for the next financial year.
Find out moreWhat is the trend in the Globe Life share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Globe Life. Over the past six months, its share price has outperformed the S&P500 Index by +23.25%.
As of the last closing price of $122.96, shares in Globe Life were trading +11.35% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Globe Life PE Ratio?
The Globe Life PE ratio based on its reported earnings over the past 12 months is 8.7. The shares last closed at $122.96.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Globe Life?
Globe Life's management team is headed by:
- Gary Coleman - CCH
- Larry Hutchison - CCH
- Frank Svoboda - CFO
- Steven DiChiaro - CEX
- Steven Greer - CEX
- Bill Leavell - CEX
- Kenneth Matson - CEX
- James McPartland - EVP
- Jennifer Haworth - EVP
- R. Brian Mitchell - EVP
- Michael Majors - EVP
- J. Matthew Darden - EVP
- Thomas Kalmbach - EVP
- M. Shane Henrie - SVP
- Christopher Moore - SVP
- Mary Henderson - SVP
- Pamela Ramirez - SVP
- Joel Scarborough - SVP
- Dolores Skarjune - SVP
- Rebecca Zorn - SVP
- Robert Ingram - LED
- Charles Adair - IND
- Linda Addison - IND
- Marilyn Alexander - IND
- Cheryl Alston - IND
- Mark Blinn - IND
- James Brannen - IND
- Jane Buchan - IND
- Steven Johnson - IND
- Darren Rebelez - IND
- Mary Thigpen - IND